Search

everythinglearnresearchcommunity

for

Search:↓

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Most hair disorder patients at the clinic were young adult males, with alopecia areata being the most common condition.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most sunscreens meet safety standards, but tanning products often don't.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Most Sudanese married women in the study used contraceptives and knew about them, but many didn't know about emergency contraceptives or extra benefits beyond family planning.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

Most over-the-counter hair loss treatments lack strong evidence of effectiveness, except for minoxidil, which works but stops working if you stop using it.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Most patients experienced significant but reversible hair loss during treatment.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Most bald men don't protect their scalp from the sun, and doctors should encourage prevention.

Most people worried about abnormal hair loss actually have psychological issues like depression or anxiety.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Most emerging dermatological treatments lack strong evidence and require more research.

Most hair dye allergies are caused by para-phenylenediamine (PPD), and safer hair dye options are needed.

Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.

Most ingredients in hair loss shampoos lack strong evidence of effectiveness.

Most patients were satisfied with topical finasteride, and few experienced side effects.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Most adverse reactions to the treatment were mild, with nausea being the most common.